A once-yearly intravenous infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis

September 2007
ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p31
Academic Journal
The article presents a study to determine whether a yearly intravenous infusion of zoledronic acid prevented, fractures in postmenopausal women suffering from osteoporosis. The methods, design and setting of the study have been discussed. Patients for the study included postmenopausal women receiving an intravenous infusion of zoledronic acid or medicine. The results concluded that a yearly intravenous infusion of zoledronic acid prevented, fractures in postmenopausal women with osteoporosis.


Related Articles

  • Minimize your risk of fractures. ETINGIN, ORLI R. // Women's Health Advisor;Jan2016, Vol. 20 Issue 1, p1 

    The article offers suggestions for women to prevent fractures including measurement of bone density to assess risk of fracture, exercise and dairy consumption by women who are at risk of osteoporosis at menopause and checking vitamin D.

  • A once-yearly intravenous infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis: COMMENTARY. Johnson, Bruce E. // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p31 

    The article discusses the implications of bisphosphonate usage in prevention of fractures in post menopausal women suffering from osteoporosis. It is mentioned that the results of bisphosphonate infusion is similar to that of oral consumption of bisphosphonates therefore oral treatment would...

  • Calcium plus Vitamin D for Postmenopausal Women – Bone Appétit? Finkelstein, Joel S. // New England Journal of Medicine;2/16/2006, Vol. 354 Issue 7, p750 

    The article presents the comments of the author on the efficacy of calcium and vitamin D for the prevention of fractures among post menopausal women. According to the author, the beneficial effect of calcium with vitamin D supplementation is insignificant for women undergoing hormone-replacement...

  • Long-term safety of alendronate established in 10-year study.  // Formulary;May2004, Vol. 39 Issue 5, p249 

    Reports on a study published in a 2004 issue of "The New England Journal of Medicine" indicating that postmenopausal women maintained or increased their bone density and prevented osteoporosis-related fractures through continuous treatment with alendronate daily for ten years. Gradual diminution...

  • MENOPAUSE MANAGEMENT, PART 2: MAINTAINING LATE MENOPAUSAL HEALTH. Burki, Regula // Cortlandt Forum;08/25/2000, Vol. 13 Issue 8, p163 

    Part II. Focuses on the relevance of health maintenance in late menopause in the United States. Comparison between vasomotor symptoms duration in natural and surgical menopause; Threat of cardiovascular disease to postmenopausal life; Importance of triglyceride recommendation; Details of...

  • Use of Oral Bisphosphonates in Primary Prevention of Fractures in Postmenopausal Women: A Population-Based Cohort Study. Real, Jordi; Galindo, Gisela; Galván, Leonardo; Lafarga, María Antonia; Rodrigo, María Dolors; Ortega, Marta // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Oral bisphosphonates are first-line drugs in the treatment of osteoporosis under most guidelines, and have been shown to decrease risk of first fracture only in asymptomatic vertebral fractures and in clinical trial populations that are generally very different from the general population....

  • Conserving the skeleton. Hillard, Tim // Journal of the British Menopause Society;2004 Supplement, Vol. 10, p7 

    The article discusses the new strategies developed in addition to existing treatments of postmenopausal osteoporosis in Great Britain. The two factors which influence the risk of osteoporosis include peak bone mass which is said to need long-term skeleton conservation and bone loss said to...

  • Exercise eases menopause. S. Y. // Prevention;Aug2005, Vol. 57 Issue 8, p52 

    The article mentions the positive effect of exercise on menopausal women. A 3-year German study of 78 early postmenopausal women found that those who did an hour of aerobic and strength-training exercises 4 days a week had fewer migraines, mood swings, and bouts with insomnia than their...

  • Effect of Lower Doses of Conjugated Equine Estrogens With and Without Medroxyprogesterone Acetate on Bone in Early Postmenopausal Women. Lindsay, Robert; Gallagher, J. Christopher; Kleerekoper, Michael; Pickar, James H. // JAMA: Journal of the American Medical Association;5/22/2002, Vol. 287 Issue 20, p2668 

    Context: Lower-than-commonly-prescribed doses of conjugated equine estrogens (CEEs) with medroxyprogesterone acetate (MPA) improve vasomotor symptoms and vaginal atrophy, provide acceptable bleeding and lipid profiles, and afford endometrial protection. This lower-dose therapy's protection...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics